-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
-
Summary
-
ArriVent BioPharma, Inc. quarterly and annual General and Administrative Expense in USD history and change rate from 31 Mar 2023 to 31 Dec 2025.
- ArriVent BioPharma, Inc. General and Administrative Expense for the quarter ending 31 Dec 2025 was $6,648,000, a 88% increase year-over-year.
- ArriVent BioPharma, Inc. General and Administrative Expense for the twelve months ending 31 Dec 2025 was $24,183,000, a 58% increase year-over-year.
- ArriVent BioPharma, Inc. annual General and Administrative Expense for 2025 was $24,183,000, a 58% increase from 2024.
- ArriVent BioPharma, Inc. annual General and Administrative Expense for 2024 was $15,304,000, a 58% increase from 2023.